Healthcare


 Why CSL Shares Are Drawing Fresh Attention on the ASX

Why CSL Shares Are Drawing Fresh Attention on the ASX

May 28, 2026 02:50 PM AEST| By Sam

CSL shares remain in focus as healthcare demand, global expansion, and interest in ASX dividend stocks continue to support attention toward the biotechnology giant.

 Why CSL’s Sharp Slide Is Putting the Healthcare Giant Back in Focus

Why CSL’s Sharp Slide Is Putting the Healthcare Giant Back in Focus

May 28, 2026 02:00 PM AEST| By Sam

CSL shares remain closely watched as the biotechnology giant navigates valuation pressure and long-term healthcare growth trends.

 Why ASX 200 Healthcare Stock Telix Pharmaceuticals Is Drawing Fresh Market Attention

Why ASX 200 Healthcare Stock Telix Pharmaceuticals Is Drawing Fresh Market Attention

May 28, 2026 10:02 AM AEST| By Sam

Telix Pharmaceuticals Ltd (ASX:TLX) gained attention after advancing its glioblastoma therapy program, with investors closely watching radiopharmaceutical growth opportunities, clinical trial progress, and the company’s expanding neuro-oncology strat...

 Recce Pharmaceuticals Expands Reach Across MENA Healthcare Markets

Recce Pharmaceuticals Expands Reach Across MENA Healthcare Markets

May 27, 2026 07:31 PM AEST| By Sam

Recce Pharmaceuticals expands into the MENA healthcare market with a long-term licensing arrangement for diabetic foot infection treatment, strengthening focus on pharmaceutical innovation and regional healthcare accessibility.

 What Sets Top ASX Healthcare Stocks Apart in 2026

What Sets Top ASX Healthcare Stocks Apart in 2026

May 27, 2026 06:15 PM AEST| By Sam

ASX healthcare stocks require analysis of product technology, research investment, geographic reach, competitive strength, reimbursement settings, regulation and capital allocation across global healthcare markets.

 Why ASX Healthcare Shares Keep Testing Market Nerves

Why ASX Healthcare Shares Keep Testing Market Nerves

May 27, 2026 05:49 PM AEST| By Sam

ASX healthcare shares face risks from regulation, currency swings, operational costs, and competition, with CSL volatility highlighting why diversification and sector awareness remain important across Australian healthcare portfolios.

 ASX 200 Healthcare Stocks: Key Aussie Sector Leaders

ASX 200 Healthcare Stocks: Key Aussie Sector Leaders

May 27, 2026 05:47 PM AEST| By Sam

ASX healthcare stocks span biotherapies, medical devices, diagnostics, software, hospitals and specialty biotechnology, offering defensive exposure shaped by innovation, regulation, global demand and company execution.

 Cochlear Strengthens Healthcare Market Presence Amid Industry Focus

Cochlear Strengthens Healthcare Market Presence Amid Industry Focus

May 27, 2026 02:56 PM AEST| By Sam

Cochlear’s market position, healthcare sector strength, and global hearing solutions business continue drawing attention across the [ASX 100] and broader Australian equities market.

 Why Tech Stocks Outshone Banks on a Tense ASX Stock Day

Why Tech Stocks Outshone Banks on a Tense ASX Stock Day

May 27, 2026 01:55 PM AEST| By Sam

Australian technology stocks gained momentum while financial shares weakened as oil prices, geopolitical tensions, and global growth themes reshaped market sentiment across several key sectors.

 Could Memphasys Be the Next Fertility Tech Story to Watch?

Could Memphasys Be the Next Fertility Tech Story to Watch?

May 27, 2026 11:46 AM AEST| By Sam

Memphasys has drawn market attention after Felix cartridge developments highlighted growing commercial momentum and broader interest in fertility-focused healthcare technologies within Australia’s biotechnology sector.

 What’s Fueling Fresh Buzz Around Aroa BioSurgery?

What’s Fueling Fresh Buzz Around Aroa BioSurgery?

May 26, 2026 05:51 PM AEST| By Sam

Aroa BioSurgery continues expanding within regenerative healthcare as innovation, hospital adoption trends and healthcare demand shape attention across the Australian healthcare sector.

 ASX Biotech Stocks: Big Rewards, Bigger Risks

ASX Biotech Stocks: Big Rewards, Bigger Risks

May 26, 2026 04:12 PM AEST| By Sam

Biotechnology investments offer the highest potential returns in healthcare alongside the highest failure rates, demanding specialised evaluation approaches from Australian investors.

 PainChek (ASX:PCK) Appoints Lilian Bianchi as Director Amid Digital Health Expansion

PainChek (ASX:PCK) Appoints Lilian Bianchi as Director Amid Digital Health Expansion

May 26, 2026 04:10 PM AEST| By Sam

Highlights,• PainChek Ltd (ASX:PCK) appointed Lilian Bianchi as Director effective 25 May 2026.,• Appendix 3X filing disclosed nil initial holdings in PCK securities.,• PCK shares remained flat at AUD 0.15 following the announcement.,• The update is...

 Why Healthcare Stocks Can Surprise ASX Investors

Why Healthcare Stocks Can Surprise ASX Investors

May 26, 2026 04:09 PM AEST| By Sam

Healthcare investments face regulatory, innovation, pricing and operational risks that require diversification, long-term positioning and ongoing monitoring across evolving healthcare markets.

 Why Healthcare Stocks Keep Drawing Market Attention

Why Healthcare Stocks Keep Drawing Market Attention

May 26, 2026 04:06 PM AEST| By Sam

Healthcare stocks continue attracting market attention through demographic growth, biotechnology innovation, essential demand and expanding global healthcare services, making the sector one of the most influential parts of the Australian market.

 Oil Shock Rattles ASX 200 Today as Market Mood Turns Fragile

Oil Shock Rattles ASX 200 Today as Market Mood Turns Fragile

May 26, 2026 02:09 PM AEST| By Sam

Australian shares weakened as oil price volatility and geopolitical tensions pressured market sentiment, with property and financial stocks dragging lower while selected healthcare and retail companies managed to outperform.

 Healthcare Giant Surges After Strong FY26 Earnings Beat

Healthcare Giant Surges After Strong FY26 Earnings Beat

May 26, 2026 11:15 AM AEST| By Sam

Fisher & Paykel Healthcare surged after delivering strong FY26 earnings growth, improving margins, and continued momentum across respiratory care and sleep therapy markets.

 Why This Healthcare Giant Is Surging On FY26 Results

Why This Healthcare Giant Is Surging On FY26 Results

May 26, 2026 11:09 AM AEST| By Sam

Fisher & Paykel Healthcare shares surged after strong FY26 earnings, improving margins, and continued growth across respiratory care and sleep therapy markets.

 Why Ryman Healthcare’s Turnaround Is Starting to Look Real

Why Ryman Healthcare’s Turnaround Is Starting to Look Real

May 26, 2026 10:03 AM AEST| By Sam

Ryman Healthcare has returned to focus as stronger free cash flow, improving aged care profitability, and balance sheet recovery strengthen confidence in the company’s long-term operational turnaround.

 CSL Share Price Outlook: Key Metrics Shaping Investor Focus

CSL Share Price Outlook: Key Metrics Shaping Investor Focus

May 25, 2026 03:41 PM AEST| By Sam

Explore how CSL’s financial performance, healthcare leadership, and global operations continue shaping market attention across the Australian share market and major healthcare indices.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.